Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Misbranding Action Clarification Sought By WLF In Appeals Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA should not be allowed to pursue a misbranding action based solely on the dissemination of information that complies with the district court's injunction in Washington Legal Foundation v. Henney permitting manufacturer-sponsored dissemination of peer-reviewed journal articles and medical texts, WLF argues in its Nov. 8 appellate brief.
Advertisement

Related Content

WLF Decision Opens Door To Off-Label Promotion With Journal Reprints
WLF Decision Opens Door To Off-Label Promotion With Journal Reprints
Advertisement
UsernamePublicRestriction

Register

MT012566

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel